Literature DB >> 18423620

Expression and distribution of MMPs and TIMPs in human uveal melanoma.

K Lai1, R M Conway, R Crouch, M J Jager, M C Madigan.   

Abstract

Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) are involved in tumour invasion, metastasis and angiogenesis, and have been implicated as progression markers in uveal melanoma, although their topographical expression has not been fully described. In this study we compared the distribution and specificity of several classes of MMPs (MMP-1, -2, -9, -19, and MT1-MMP) and physiological MMP inhibitors (TIMP-2 and -3) in different regions of the tumour microenvironment and adjacent choroid in a series of primary uveal melanomas. Paraffin sections of untreated uveal melanomas (n=18, 3/18 spindle; 11/18 mixed, and 4/18 epithelioid) were examined for MMP-1 (collagenase 1), MMP-2 and MMP-9 (gelatinases A and B), MT1-MMP (membrane-type 1-MMP), MMP-19, TIMP-2 and TIMP-3 (tissue inhibitors of MMPs), using indirect peroxidase immunohistochemistry. The distribution and intensity of immunolabelling was graded semi-quantitatively (0-3) by 2 independent observers. Non-parametric analyses were used to test for associations between tumour cell type, and the average grade of MMP or TIMP expression. Immunostaining for MMP-1, -9, -19 and MT1-MMP was > or =Grade 2 in more than 70% of specimens, and a heterogeneous pattern of MMP-1, -9, MT1-MMP and TIMP-3 expression was observed. At the tumour-scleral interface (TSI), melanoma cells had a flattened morphology and a much reduced MMP and TIMP expression, with a high expression in tumour areas adjacent to the TSI. Tumour vasculature and stromal cells strongly expressed MMP-2. We also observed heterogeneous immunostaining of the vasculature by MMP-1, -9, MT1-MMP and TIMP-2 antibodies, and of the extravascular matrix by MMP-9 antibody. The distinct immunostaining patterns observed for MMPs and TIMPs within uveal melanoma are consistent with their involvement in tumour growth and angiogenesis. In particular, the heterogeneous expression within regions of the tumours, and the localized expression in vasculature and stromal cells emphasises the importance of the tumour microenvironment in the pathogenesis of uveal melanoma (and other tumours).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423620     DOI: 10.1016/j.exer.2008.03.010

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  10 in total

1.  Tight junction-associated signaling pathways modulate cell proliferation in uveal melanoma.

Authors:  Ashwath Jayagopal; Jin-Long Yang; Frederick R Haselton; Min S Chang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-01       Impact factor: 4.799

2.  Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism.

Authors:  Jian Hua Qi; Bela Anand-Apte
Journal:  Apoptosis       Date:  2015-04       Impact factor: 4.677

Review 3.  The Role of Metalloproteinases and Their Tissue Inhibitors on Ocular Diseases: Focusing on Potential Mechanisms.

Authors:  Miłosz Caban; Katarzyna Owczarek; Urszula Lewandowska
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

4.  Des-gamma-carboxy prothrombin stimulates human vascular endothelial cell growth and migration.

Authors:  Su-Bo Wang; Yan-Na Cheng; Shu-Xiang Cui; Julia Li Zhong; S G Ward; Li-Rui Sun; Ming-Hui Chen; Norihiro Kokudo; Wei Tang; Xian-Jun Qu
Journal:  Clin Exp Metastasis       Date:  2009-03-05       Impact factor: 5.150

5.  Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma.

Authors:  Liang Wang; Jun Yuan; Yanyang Tu; Xinggang Mao; Shiming He; Guoqiang Fu; Jianhai Zong; Yongsheng Zhang
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

Review 6.  Blood biomarkers for uveal melanoma.

Authors:  Pierre L Triozzi; Arun D Singh
Journal:  Future Oncol       Date:  2012-02       Impact factor: 3.674

Review 7.  Blood Biomarkers of Uveal Melanoma: Current Perspectives.

Authors:  Manuel F Bande Rodríguez; Beatriz Fernandez Marta; Nerea Lago Baameiro; Maria Santiago-Varela; Paula Silva-Rodríguez; María Jose Blanco-Teijeiro; Maria Pardo Perez; Antonio Piñeiro Ces
Journal:  Clin Ophthalmol       Date:  2020-01-20

8.  Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression.

Authors:  Mieszko Lachota; Anton Lennikov; Karl-Johan Malmberg; Radoslaw Zagozdzon
Journal:  J Immunol Res       Date:  2021-06-11       Impact factor: 4.818

9.  Nonlethal Levels of Zeaxanthin Inhibit Cell Migration, Invasion, and Secretion of MMP-2 via NF-κB Pathway in Cultured Human Uveal Melanoma Cells.

Authors:  Ming-Chao Bi; Nicole Hose; Cai-Lian Xu; Chen Zhang; Jodi Sassoon; E Song
Journal:  J Ophthalmol       Date:  2016-01-28       Impact factor: 1.909

10.  Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma.

Authors:  Jing Zhang; Shenglan Liu; Qianyun Ye; Jingxuan Pan
Journal:  Mol Cancer       Date:  2019-09-16       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.